Form 4: GE HealthCare CFO James Saccaro Reports Stock and Option Awards

Chief Financial Officer James Saccaro reported the acquisition of restricted stock units and employee stock options in GE HealthCare Technologies Inc.

Summary

• On March 1, 2024, James Saccaro, CFO of GE HealthCare Technologies Inc., reported transactions involving the company's stock.
• Saccaro was awarded 10,245 restricted stock units (RSUs) and an employee stock option for 29,141 shares.
• The RSUs will vest in three tranches: 33% on September 1, 2025, 33% on September 1, 2026, and 34% on September 1, 2027, subject to certain conditions.
• The employee stock options also vest in three tranches: 33% exercisable on September 1, 2025, 33% on September 1, 2026, and 34% on September 1, 2027, subject to certain conditions.
• The exercise price for the stock options is $92.72.
• Following these transactions, Saccaro directly owns 71,938 shares of GE HealthCare common stock.
• Frank R. Jimenez, General Counsel and Corporate Secretary, signed the report as attorney-in-fact on March 5, 2024.

Sentiment

Score: 6

Explanation: The document is a neutral regulatory filing. The sentiment is moderately positive as it reflects standard executive compensation practices.

Positives

• The award of restricted stock units and stock options to the CFO aligns his interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CFO.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the awarded equity.

Industry Context

This filing is a routine disclosure of insider transactions, common for publicly traded companies. It provides transparency into the compensation structure and equity ownership of key executives.

Comparison to Industry Standards

• Equity compensation is a standard practice among publicly traded companies to incentivize executives.
• Vesting schedules are common to ensure long-term commitment.
• The specific amounts and terms of the awards would need to be compared to peer companies in the healthcare technology sector to assess their competitiveness.
• Companies like Siemens Healthineers, Philips, and Medtronic also utilize equity compensation for their executives.

Stakeholder Impact

• The equity awards align management's interests with shareholders, potentially driving long-term value creation.
• Employees may view the equity awards positively, as they are a common form of executive compensation.

Key Dates